Loading...
OTCMHALMY
Market cap12bUSD
Dec 23, Last price  
69.75USD
1D
-0.11%
1Q
-0.41%
Name

Halma PLC

Chart & Performance

D1W1MN
OTCM:HALMY chart
P/E
78.19
P/S
10.33
EPS
0.71
Div Yield, %
0.30%
Shrs. gr., 5y
-0.02%
Rev. gr., 5y
10.93%
Revenues
2.03b
+9.79%
268,719,000310,768,000351,119,000395,061,000455,928,000459,118,000518,428,000579,883,000619,210,000676,506,000726,134,000807,805,000961,662,0001,076,200,0001,210,900,0001,338,400,0001,318,200,0001,525,300,0001,852,800,0002,034,100,000
Net income
269m
+14.63%
34,551,00040,875,00044,011,00050,284,00052,581,00060,437,00072,434,00086,714,00095,216,000106,327,000104,001,000108,841,000129,689,000154,228,000169,800,000184,400,000203,400,000244,400,000234,500,000268,800,000
CFO
385m
+59.62%
46,055,00051,907,00048,860,00055,928,00062,626,00099,291,00094,239,00096,197,000108,244,000121,538,000137,231,000149,273,000172,493,000173,300,000219,000,000244,900,000268,399,999229,400,000241,200,000385,000,000
Dividend
Jul 12, 20240.334 USD/sh
Earnings
Jun 11, 2025

Profile

Halma plc, through its subsidiaries, provides technology solutions in the safety, health, and environmental markets. It operates through three segments: Safety, Environmental & Analysis, and Medical. The Safety segment provides fire detection, specialist fire suppression, elevator safety, security sensors, people and vehicle flow technologies, specialized interlocks that control critical processes safely, and explosion protection and corrosion monitoring systems. This segment serves elevator safety, fire suppression, people and vehicle flow, fire detection, pressure management, industrial access control, and safe storage and transfer markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; water, air and gases monitoring technologies; instruments that detect hazardous gases and analyses air quality; and systems for water analysis and treatment. It serves the optical analysis, water analysis and treatment, gas detection, and environmental monitoring markets. The Medical segment provides critical fluidic components used by medical diagnostics and original equipment manufacturers; laboratory devices and systems that provide information to understand patient health and enable providers to make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable positive outcomes across clinical specialties. This segment serves the life sciences, health assessment, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
IPO date
Jan 03, 1986
Employees
8,000
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
2,034,100
9.79%
1,852,800
21.47%
1,525,300
15.71%
Cost of revenue
1,783,700
1,643,200
1,344,600
Unusual Expense (Income)
NOPBT
250,400
209,600
180,700
NOPBT Margin
12.31%
11.31%
11.85%
Operating Taxes
71,500
57,200
60,200
Tax Rate
28.55%
27.29%
33.31%
NOPAT
178,900
152,400
120,500
Net income
268,800
14.63%
234,500
-4.05%
244,400
20.16%
Dividends
(78,200)
(73,300)
(68,700)
Dividend yield
0.87%
0.87%
0.72%
Proceeds from repurchase of equity
(21,100)
(234,600)
(20,700)
BB yield
0.24%
2.78%
0.22%
Debt
Debt current
19,800
20,200
88,000
Long-term debt
859,800
746,000
344,200
Deferred revenue
18,800
17,100
14,600
Other long-term liabilities
16,900
82,500
68,200
Net debt
717,100
575,700
266,600
Cash flow
Cash from operating activities
385,000
241,200
229,400
CAPEX
(32,800)
(45,900)
(40,000)
Cash from investing activities
(287,500)
(369,600)
(134,900)
Cash from financing activities
(119,700)
138,500
(73,700)
FCF
135,200
(2,200)
36,200
Balance
Cash
142,700
169,500
157,400
Long term investments
19,800
21,000
8,200
Excess cash
60,795
97,860
89,335
Stockholders' equity
1,770,900
1,621,400
1,410,200
Invested Capital
2,507,305
2,280,940
1,761,665
ROIC
7.47%
7.54%
7.35%
ROCE
9.46%
8.56%
9.46%
EV
Common stock shares outstanding
378,700
379,100
379,400
Price
23.68
6.24%
22.29
-11.20%
25.10
5.73%
Market cap
8,967,616
6.12%
8,450,139
-11.27%
9,522,940
5.80%
EV
9,684,716
9,025,939
9,789,940
EBITDA
356,000
311,100
269,300
EV/EBITDA
27.20
29.01
36.35
Interest
29,600
18,300
8,700
Interest/NOPBT
11.82%
8.73%
4.81%